SCOPUS 정보 검색 플랫폼

Drugs of the Future

Volumn 25, Issue 11, 2000, Pages 1145-1149

Rufinamide. Antiepileptic, treatment of neurogenic pain

(4) Sorbera, L A a Leeson, P A a Rabasseda, X a Castaner J a

a PROUS SCIENCE (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AWD 34 022; CARBAMAZEPINE; ETHOSUXIMIDE; FOSPHENYTOIN SODIUM; GW 273293; LAMOTRIGINE; LICARBAZEPINE; OXCARBAZEPINE; PHENYTOIN; RUFINAMIDE; UNCLASSIFIED DRUG; VALPROIC ACID; ZONISAMIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; EPILEPSY; HUMAN; MULTICENTER STUDY; PAIN; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0034500434 PISSN: 03778282 EISSN: None Source Type: Journal
DOI: 10.1358/dof.2000.025.11.599595 Document Type: Review

Times cited : (16)

References (24)

1
- 0006417493
- Fluorinated benzyltriazole derivs. AU 8656319, EP 0199262, ES 8800176, ES 8802501, JP1986243068
- Meier, R.¹

2
- 0006456307
- Process for preparing 1-substd. 4-cyano-1,2,3-triazoles. WO 9802423
- Portmann, R.¹

3
- 0006417494
- Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic. WO 9856772, WO 9856773
- Portmann, R.¹ Hofmeier, U.C.² Burkhard, A.³ Scherrer, W.⁴ Szelagiewicz, M.⁵

4
- 4243676398
- Updated October 30
- Epilepsy (online publication) , pp. 2000

5
- 0002376924
- Principles of antiepileptic drugs
- Anti-Epileptic Drugs, R.H. Levy, R.H. Mattson and B.S. Meldrum (Eds.), Raven Press, New York
- (1995) , pp. 61-77
- McDonald, R.L.¹ Meldrum, B.S.²

6
- 0006756610
- Evaluation of rufinamide (CGP 33101), a novel anticonvulsant, for potential drug interactions in vitro
- Abst 1.96
- (1996) Epilepsia , vol.37 , Issue.SUPPL. 5
- Kapeghian, J.C.¹ Madan, A.² Parkinson, A.³ Tripp, S.L.⁴ Probst, A.⁵

7
- 0028860734
- Progress report on new antiepileptic drugs: A summary of the Second Eilat Conference
- (1995) Epilepsy Res , vol.22 , pp. 235-246
- Stables, J.P.¹ Bialer, M.² Johannessen, S.I.³ Kupferberg, H.J.⁴ Levy, R.H.⁵ Loiseau, P.⁶ Perucca, E.⁷

8
- 0030297333
- Progress report on new antiepileptic drugs: A summary of the Third Eilat Conference
- (1996) Epilepsy Res , vol.25 , pp. 299-319
- Bialer, M.¹ Johannessen, S.I.² Kupferberg, H.J.³ Levy, R.H.⁴ Loiseau, P.⁵ Perucca, E.⁶

9
- 0033061573
- Progress report on new antiepileptic drugs: A summary of the Fourth Eilat Conference (EILAT IV)
- (1999) Epilepsy Res , vol.34 , pp. 1-41
- Bialer, M.¹ Johannessen, S.I.² Kupferberg, H.J.³ Levy, R.H.⁴ Loiseau, P.⁵ Perucca, E.⁶

10
- 0000946466
- Anticonvulsant profile of CGP 33101 in animals
- (1993) Epilepsia , vol.34 , Issue.SUPPL. 2 , pp. 122
- Schmutz, M.¹ Allgeier, H.² Jeker, A.³

11
- 0026497748
- An automated method for the determination of a new potential antiepileptic agent (CGP 33101) in human plasma using high performance liquid chromatography
- (1992) Biomed Chromatogr , vol.6 , pp. 278-282
- Brunner, L.A.¹ Powell, M.L.²

12
- 0028997621
- Automated analysis of a novel anti-epileptic compound, CGP 33101, and its metabolite, CGP 47292, in body fluids by high-performance liquid chromatography and liquid-solid extraction
- (1995) J Chromatogr B - Biomed Appl , vol.667 , pp. 307-313
- Rouan, M.C.¹ Souppart, C.² Alif, L.³ Moes, D.⁴ Lecaillon, J.B.⁵ Godbillon, J.⁶

13
- 0000029301
- Metabolism of the new anticonvulsant trial drug rufinamide (CGP 33101) in healthy male volunteers
- Abst 6.60
- (1996) Epilepsia , vol.37 , Issue.SUPPL. 5
- Waldmeier, F.¹ Gschwind, H.-P.² Rouan, M.-C.³ Sioufi, A.⁴ Czendlik, C.⁵

14
- 0029566317
- Intra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200-mg tablets and 400-mg suspension
- (1995) Pharm Res , vol.12 , pp. 1878-1882
- Cheung, W.K.¹ Kianifard, F.² Wong, A.³ Mathieu, J.⁴ Cook, T.⁵ John, V.⁶ Redalieu, E.⁷ Chan, K.⁸

15
- 0031959729
- The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers
- (1998) Biopharm Drug Dispos , vol.19 , pp. 259-262
- Cardot, J.-M.¹ Lecaillon, J.-B.² Czendlik, C.³ Godbillon, J.⁴

16
- 0006756605
- A geriatric pharmacokinetic evaluation of rufimamide
- Abst PIII-48
- (2000) Clin Pharmacol Ther , vol.67 , Issue.2
- Chang, S.W.¹ Yeh, C.M.² Van Logtenberg, M.³ Sedek, G.⁴ Karolchyk, M.A.⁵

17
- 0006480473
- Abst 2.110
- (1998) A pharmacokinetic evaluation of rufinamide in elderly and younger subjects. Epilepsia , vol.39 , Issue.SUPPL. 6
- Chang, S.-W.¹ Choi, L.² Karolchyk, M.A.³

18
- 0000489497
- Pharmacokinetics and safety of adjunctive rufinamide therapy in pediatric patients with epilepsy
- Abst 5.081
- (1998) Epilepsia , vol.39 , Issue.SUPPL. 6
- Sachdeo, R.C.¹ Rosenfeld, W.E.² Choi, L.³ Yeh, C.-M.⁴ Cooper, A.N.⁵ Karolchyk, M.A.⁶

19
- 0006492632
- Single-center, open-label, multiple-dose pharmacokinetic trial investigating the effect of rufinamide administration on Ortho-Novum 1/35 in healthy women
- Abst 2.111
- (1998) Epilepsia , vol.39 , Issue.SUPPL. 6
- Svendsen, K.D.¹ Choi, L.² Chen, B.-L.³ Karolchyk, M.A.⁴

20
- 0029887507
- The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine
- (1996) Clin Pharmacokin , vol.31 , pp. 29-46
- Perucca, E.¹ Bialer, M.²

21
- 0000354744
- Efficacy and safety of rufinamide in patients with refractory epilepsy
- Abst 1-10
- (1997) Epilepsia , vol.38 , Issue.SUPPL. 8
- Palhagen, S.¹ Canger, R.² Henriksen, O.³ Van Parys, J.A.⁴ Karolchyk, M.A.⁵

22
- 0006490626
- Safety and efficacy of open-label rufinamide as adjunctive therapy in pediatric patients with partial seizures
- Abst 2.119
- (1999) Epilepsia , vol.40 , Issue.SUPPL. 7
- Litzinger, M.J.¹ Hanny, A.²

23
- 0006454512
- Rufinamide: Update
- June 25-29, Eilat
- (2000) 5th Eilat Conf New Antiepileptic Drugs , pp. 30
- Rosenfeld, W.E.¹ Karolchyk, M.A.²

24
- 4244035224
- Novartis Product Pipeline October 30
- (2000) Compounds in development

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.